About Index Trending news
Lists
Pricing

Therapeutics

200+ Companies
Companies
256
Established hub
Deals 2018 Q1
20 investments
No acquisitions
Index Pro Account
Upgrade your account to download a CSV export of companies on any list
Xconomy

Bio Roundup: Lung Cancer Showdown, Gene Therapy Deals, IPO Busts

Health Stock markets
$50,000,000 Venture capital (Series A)
FinSMEs

Sollis Therapeutics Receives up to $50m Investment from Deerfield Management

Health Funding
£29,000,000 Venture capital (Series B)
PE Hub

Enterprise Therapeutics raises 29 mln pounds

Messaging
FinSMEs

Enterprise Therapeutics Raises £29M in Funding

Health Funding
Xconomy

With Alzheimer’s Failure, vTv Fares No Better Than Old Partner Pfizer

Health Science
$3,900,000 Venture capital
FinSMEs

Zucara Therapeutics Secures US$3.9M in Non-Dilutive Funding

Health Science
Xconomy

Xconomy Roadmap 2018: Top 15 Innovation Areas to Watch

Health Technology
Undisclosed funding
FinSMEs

Sigilon Therapeutics Receives Investment from Eli Lilly and Company

Health Funding Software development
Xconomy

Arcturus Proxy Fight Heats Up; Ex-CEO Responds to Board’s Charges

Strategy Legal
Venture Funding News

Poseida Therapeutics Hauls in $30.5M Series B

$30,500,000 Venture capital (Series B)
PE Hub , FinSMEs , Venture Funding News

Poseida Therapeutics snags $30.5 mln Series B

Messaging
PE Hub

VC-backed Relay Therapeutics adds three to staff

Funding Health Science
PE Hub , Xconomy

VC-backed Roche Holdings buys Inception 5 program

Funding Science
Undisclosed funding
PE Hub , FinSMEs

Allogene Therapeutics grabs funding from Vida Ventures

Funding
PE Hub

Bridge Medicines appoints chief scientific officer

Health
Xconomy

Bio Roundup: Biotech IPOs, Migraine Progress, Takeda Woos Shire & More

Health
Xconomy

Arcturus Board Sues Ex-CEO, Alleges Deceit, in Prelude to Proxy Fight

Strategy Science
$69,200,000 IPO
PE Hub

VC-backed Unum Therapeutics rolls out IPO

Stock markets Health
Xconomy

Unum Therapeutics IPO Raises $69M to Test Universal Cell Therapies

Health Stock markets
Xconomy

Edge to Cut Jobs as Head Injury Drug Flops in Phase 3, Shares Tumble

Health